Education Information
2019 - Continues
2019 - ContinuesPost Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Division Of Medical Sciences , Turkey
Dissertations
2019
2019Expertise In Medicine
Beta talasemi minörde serum endokan düzeyi / Serum endocan levels in beta thalassemia minor
Istanbul University
Foreign Languages
B1 Intermediate
B1 IntermediateEnglish
Published journal articles indexed by SCI, SSCI, and AHCI
2024
2024Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study
Ferhatoglu F., Paksoy N., Khanmammadov N., YILDIZ A., AHMED M. A., Gülbas Z., et al.
Medicine
, vol.103, no.8, 2024 (SCI-Expanded)
2024
2024Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer
Khanmammadov N., Doǧan I., Okay N. S., AZİZY A., Saip P., AYDINER A.
Medicine (United States)
, vol.103, no.1, 2024 (SCI-Expanded)
2024
2024Outcomes of the patients with metastatic male breast cancer
Dogan I., Khanmammadov N., ÖZKURT S., AYDINER A., Saip P.
Journal of Cancer Research and Therapeutics
, vol.20, no.1, pp.98-102, 2024 (SCI-Expanded)
2023
2023Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Saip P., AYDINER A.
Scientific Reports
, vol.13, no.1, 2023 (SCI-Expanded)
2023
2023Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients
DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.
Journal of Cancer Research and Clinical Oncology
, vol.149, no.16, pp.14833-14841, 2023 (SCI-Expanded)
2023
2023Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience
TAŞTEKİN D., Paksoy N., DOĞAN İ., Ferhatoglu F., KHANMAMMADOV N., Bozbey H. U., et al.
Journal of cancer research and therapeutics
, vol.19, no.2, pp.253-258, 2023 (SCI-Expanded)
2022
2022Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group
GÜRBÜZ M., Kilickap S., BİLİCİ A., Karadurmus N., Sezer A., ŞENDUR M. A. N., et al.
MEDICINE
, vol.101, no.50, 2022 (SCI-Expanded)
2022
2022High-dose chemotherapy followed by autologous stem cell transplantation for adult patients with first relapse of Ewing's sarcoma: A single institution experience
PAKSOY N., FERHATOĞLU F., DOĞAN İ., KHANMAMMADOV N., Iribas Celik A., Gulbas Z., et al.
Medicine (United States)
, vol.101, no.49, 2022 (SCI-Expanded)
2022
2022Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study
PAKSOY N., KHANMAMMADOV N., DOĞAN İ., FERHATOĞLU F., YILDIZ A., AK N., et al.
Medicine (United States)
, vol.101, no.45, 2022 (SCI-Expanded)
2022
2022Assessment of serum endocan levels in patients with beta-thalassemia minor
Khanmammadov N., ZORLU M., ÖZER Ö. F., KARATOPRAK C., KISKAÇ M., ÇAKIRCA M.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
, vol.68, no.2, pp.147-151, 2022 (SCI-Expanded)
Articles Published in Other Journals
2024
2024Efficacy of Bevacizumab-Based Terapy in Patient With Metastatic or Recurrent Cervical Cancer: Real Life Data
KHANMAMMADOV N., Dogan I., okay n. s., Ugar M., Osmanova N., Saip P., et al.
Selçuk Tıp Dergisi
, vol.40, no.2, pp.68-73, 2024 (Peer-Reviewed Journal)
2024
2024The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience
Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.
Turk Onkoloji Dergisi
, vol.39, no.3, pp.257-264, 2024 (ESCI)
2024
2024Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer
Khanmammadov N., Doğan İ., Okay N. S., YILDIZ A., Khishigsuren B., AZİZY A., et al.
Turk Onkoloji Dergisi
, vol.39, no.2, pp.176-182, 2024 (ESCI)
2023
2023Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors
DOĞAN İ., KHANMAMMADOV N., PAKSOY N., VATANSEVER S., SAİP P., AYDINER A.
Eurasian Journal of Pulmonology
, vol.25, no.1, pp.27-32, 2023 (Peer-Reviewed Journal)
2023
2023Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study
Paksoy N., KHANMAMMADOV N., DOĞAN İ., Ferhatoǧlu F., AHMED M. A., Karaman S., et al.
Medicine (Spain)
, vol.102, no.5, 2023 (Scopus)
2022
2022Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib
DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.
CLINICAL CANCER INVESTIGATION JOURNAL
, no.4, pp.5-9, 2022 (ESCI)
2022
2022Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience
DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.
CLINICAL CANCER INVESTIGATION JOURNAL
, no.3, pp.25-29, 2022 (ESCI)
2022
2022Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study
Paksoy N., Ferhatoglu F., DOĞAN İ., Khanmammadov N., Bozbey H. U., KARABULUT S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, vol.37, no.4, pp.478-483, 2022 (ESCI)
Refereed Congress / Symposium Publications in Proceedings
2023
2023